Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Campbell

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2020
Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutationsAnne Munck, Eitan Kerem, Helmut Ellemunter, et al.
Translational Psychiatry|June 6, 2024
General and anxiety-linked influences of acute serotonin reuptake inhibition on neural responses associated with attended visceral sensationJames J A Livermore, Lina I Skora, Kristian Adamatzky, et al.
Journal of Psychopharmacology (Oxford, England)|February 19, 2021
Selective effects of serotonin on choices to gather more informationJames Ja Livermore, Clare L Holmes, Jo Cutler, et al.
Diabetes|January 20, 2009
Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivityGavin A Bewick, Aysha Kent, Daniel Campbell, et al.
Gastroenterology|February 25, 2010
The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fatJames V Gardiner, Daniel Campbell, Michael Patterson, et al.
Brain : a Journal of Neurology|April 8, 2021
Taking others into account: combining directly experienced and indirect information in schizophreniaArndis Simonsen, Riccardo Fusaroli, Malte Lau Petersen, et al.
Psychopharmacology|March 24, 2022
A single oral dose of citalopram increases interoceptive insight in healthy volunteersJames J A Livermore, Clare L Holmes, Gyorgy Moga, et al.
American Journal of Otolaryngology|January 30, 2021
Improved efficiency of sialendoscopy procedures at an ambulatory surgery centerEric Mastrolonardo, Matthew Stewart, Rahul Alapati, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 29, 2022
Long-term tezacaftor/ivacaftor safety and efficacy in people with cystic fibrosis and an F508del-CFTR mutation: 96-week, open-label extension of the EXTEND trialPatrick A Flume, R Scott Harris, Hildegarde Paz-Diaz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 19, 2020
A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutationEdward F McKone, Emily A DiMango, Sivagurunathan Sutharsan, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2020
Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutationsAnne Munck, Eitan Kerem, Helmut Ellemunter, et al.
Translational Psychiatry|June 6, 2024
General and anxiety-linked influences of acute serotonin reuptake inhibition on neural responses associated with attended visceral sensationJames J A Livermore, Lina I Skora, Kristian Adamatzky, et al.
Journal of Psychopharmacology (Oxford, England)|February 19, 2021
Selective effects of serotonin on choices to gather more informationJames Ja Livermore, Clare L Holmes, Jo Cutler, et al.
Diabetes|January 20, 2009
Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivityGavin A Bewick, Aysha Kent, Daniel Campbell, et al.
Gastroenterology|February 25, 2010
The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fatJames V Gardiner, Daniel Campbell, Michael Patterson, et al.
Brain : a Journal of Neurology|April 8, 2021
Taking others into account: combining directly experienced and indirect information in schizophreniaArndis Simonsen, Riccardo Fusaroli, Malte Lau Petersen, et al.
Psychopharmacology|March 24, 2022
A single oral dose of citalopram increases interoceptive insight in healthy volunteersJames J A Livermore, Clare L Holmes, Gyorgy Moga, et al.
American Journal of Otolaryngology|January 30, 2021
Improved efficiency of sialendoscopy procedures at an ambulatory surgery centerEric Mastrolonardo, Matthew Stewart, Rahul Alapati, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 29, 2022
Long-term tezacaftor/ivacaftor safety and efficacy in people with cystic fibrosis and an F508del-CFTR mutation: 96-week, open-label extension of the EXTEND trialPatrick A Flume, R Scott Harris, Hildegarde Paz-Diaz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 19, 2020
A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutationEdward F McKone, Emily A DiMango, Sivagurunathan Sutharsan, et al.
Pageof 7